Hormonal Modulation in Aging Patients with Erectile Dysfunction and Metabolic Syndrome

Erectile dysfunction (ED), metabolic syndrome (MetS), and hypogonadism are closely related, often coexisting in the aging male. Obesity was shown to raise the risk of ED and hypogonadism, as well as other endocrinological disturbances with impact on erectile function. We selected 179 patients referr...

Full description

Saved in:
Bibliographic Details
Main Authors: Inês Campos Costa, Hugo Nogueira Carvalho, Luís Pacheco-Figueiredo, Inês Tomada, Nuno Tomada
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2013/107869
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564192775766016
author Inês Campos Costa
Hugo Nogueira Carvalho
Luís Pacheco-Figueiredo
Inês Tomada
Nuno Tomada
author_facet Inês Campos Costa
Hugo Nogueira Carvalho
Luís Pacheco-Figueiredo
Inês Tomada
Nuno Tomada
author_sort Inês Campos Costa
collection DOAJ
description Erectile dysfunction (ED), metabolic syndrome (MetS), and hypogonadism are closely related, often coexisting in the aging male. Obesity was shown to raise the risk of ED and hypogonadism, as well as other endocrinological disturbances with impact on erectile function. We selected 179 patients referred for ED to our andrology unit, aiming to evaluate gonadotropins and estradiol interplay in context of ED, MetS, and hypogonadism. Patients were stratified into groups in accordance with the presence (or not) of MetS and/or hypogonadism. Noticeable differences in total testosterone (TT) and free testosterone (FT) levels were found between patients with and without MetS. Men with MetS evidenced lower TT circulating levels with an increasing number of MetS parameters, for which hypertriglyceridemia and waist circumference strongly contributed. Regarding the hypothalamic-pituitary-gonadal axis, patients with hypogonadism did not exhibit raised LH levels. Interestingly, among those with higher LH levels, estradiol values were also increased. Possible explanations for this unexpected profile of estradiol may be the age-related adiposity, other estrogen-raising pathways, or even unknown mechanisms. Estradiol is possibly a molecule with further interactions beyond the currently described. Our results further enlighten this still unclear multidisciplinary and complex subject, raising new investigational opportunities.
format Article
id doaj-art-52daf744f43c410db1c05ec5c3160608
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-52daf744f43c410db1c05ec5c31606082025-02-03T01:11:36ZengWileyInternational Journal of Endocrinology1687-83371687-83452013-01-01201310.1155/2013/107869107869Hormonal Modulation in Aging Patients with Erectile Dysfunction and Metabolic SyndromeInês Campos Costa0Hugo Nogueira Carvalho1Luís Pacheco-Figueiredo2Inês Tomada3Nuno Tomada4Faculty of Medicine, Universidade do Porto, Alameda Professor Hernâni Monteiro, 4200-319 Porto, PortugalFaculty of Medicine, Universidade do Porto, Alameda Professor Hernâni Monteiro, 4200-319 Porto, PortugalDepartment of Urology, São João Central Hospital, Alameda Professor Hernâni Monteiro, 4200-319 Porto, PortugalDepartment of Experimental Biology, Faculty of Medicine, Universidade do Porto, Alameda Professor Hernâni Monteiro, 4200-319 Porto, PortugalFaculty of Medicine, Universidade do Porto, Alameda Professor Hernâni Monteiro, 4200-319 Porto, PortugalErectile dysfunction (ED), metabolic syndrome (MetS), and hypogonadism are closely related, often coexisting in the aging male. Obesity was shown to raise the risk of ED and hypogonadism, as well as other endocrinological disturbances with impact on erectile function. We selected 179 patients referred for ED to our andrology unit, aiming to evaluate gonadotropins and estradiol interplay in context of ED, MetS, and hypogonadism. Patients were stratified into groups in accordance with the presence (or not) of MetS and/or hypogonadism. Noticeable differences in total testosterone (TT) and free testosterone (FT) levels were found between patients with and without MetS. Men with MetS evidenced lower TT circulating levels with an increasing number of MetS parameters, for which hypertriglyceridemia and waist circumference strongly contributed. Regarding the hypothalamic-pituitary-gonadal axis, patients with hypogonadism did not exhibit raised LH levels. Interestingly, among those with higher LH levels, estradiol values were also increased. Possible explanations for this unexpected profile of estradiol may be the age-related adiposity, other estrogen-raising pathways, or even unknown mechanisms. Estradiol is possibly a molecule with further interactions beyond the currently described. Our results further enlighten this still unclear multidisciplinary and complex subject, raising new investigational opportunities.http://dx.doi.org/10.1155/2013/107869
spellingShingle Inês Campos Costa
Hugo Nogueira Carvalho
Luís Pacheco-Figueiredo
Inês Tomada
Nuno Tomada
Hormonal Modulation in Aging Patients with Erectile Dysfunction and Metabolic Syndrome
International Journal of Endocrinology
title Hormonal Modulation in Aging Patients with Erectile Dysfunction and Metabolic Syndrome
title_full Hormonal Modulation in Aging Patients with Erectile Dysfunction and Metabolic Syndrome
title_fullStr Hormonal Modulation in Aging Patients with Erectile Dysfunction and Metabolic Syndrome
title_full_unstemmed Hormonal Modulation in Aging Patients with Erectile Dysfunction and Metabolic Syndrome
title_short Hormonal Modulation in Aging Patients with Erectile Dysfunction and Metabolic Syndrome
title_sort hormonal modulation in aging patients with erectile dysfunction and metabolic syndrome
url http://dx.doi.org/10.1155/2013/107869
work_keys_str_mv AT inescamposcosta hormonalmodulationinagingpatientswitherectiledysfunctionandmetabolicsyndrome
AT hugonogueiracarvalho hormonalmodulationinagingpatientswitherectiledysfunctionandmetabolicsyndrome
AT luispachecofigueiredo hormonalmodulationinagingpatientswitherectiledysfunctionandmetabolicsyndrome
AT inestomada hormonalmodulationinagingpatientswitherectiledysfunctionandmetabolicsyndrome
AT nunotomada hormonalmodulationinagingpatientswitherectiledysfunctionandmetabolicsyndrome